logo
logo
  • Home
  • RT SOLUTIONS
    • ART-Plan™
      • Annotate
      • SmartFuse
      • MR-Box
      • AdaptBox
  • Neuro Solutions
    • Alzheimer’s Disease
    • Multiple Sclerosis
  • Resources
    • Blog
    • Publications
  • News
  • Careers
  • Contact

Blog

Get the latest TheraPanacea news.

Explore all our information resources, including white papers, press realeases and events. If you can’t find what you’re looking for, please don’t hesitate to let us know. Send an email to mail@therapanacea.eu and we will get back to you as soon as possible.

  • Show all
  • Research

15 February 2021

Multimodal Brain Tumor Classification

15 February 2021

Magnetic Resonance Imaging Virtual Histopathology from Weakly Paired Data

15 February 2021

Improvement of a deep learning based automatic delineation model using anatomical criteria

15 February 2021

Human-level Precision Upper Abdominal OAR Contouring with Anatomically Preserving Deep Learning during Magnetic Resonance Imaging Guided Adaptive Radiotherapy (MRGRT)

15 February 2021

High-particle simulation of Monte-Carlo dose distribution with 3D ConvLSTMs

15 February 2021

Holistic artificial intelligence-driven predictor in HER2-positive (HER2+) early breast cancer (BC) treated with neoadjuvant lapatinib and trastuzumab without chemotherapy: A correlative analysis from SOLTI-1114 PAMELA

Loading…

Stay posted

Sign up to receive the latest Therapanacea news!



    FR Office
    7 bis boulevard Bourdon
    75004, Paris – France
    mail @ therapanacea.eu

    Menu
    • About us
    • Team
    • Careers
    • Product & Technology
    • Contact

    Extras
    • Legal info
    • Privacy policy
    • Sitemap

    Newsletter
    Get our latest news.

    Newsletter
    Demo
    Book a demo

    © 2021 Therapanacea™ | Web design by Domaine-Pack.fr

    Privacy Preference Center

    Privacy Preferences

    We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok